Onto Innovation (ONTO)
(Delayed Data from NYSE)
$197.93 USD
-13.98 (-6.60%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $197.93 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth B Momentum C VGM
Onto Innovation (ONTO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$259.00 | $280.00 | $230.00 | 22.22% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Onto Innovation comes to $259.00. The forecasts range from a low of $230.00 to a high of $280.00. The average price target represents an increase of 22.22% from the last closing price of $211.91.
Analyst Price Targets (5 )
Broker Rating
Onto Innovation currently has an average brokerage recommendation (ABR) of 1.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 1.33 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, five are Strong Buy, representing 83.33% of all recommendations. A month ago, Strong Buy represented 83.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/15/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/12/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
5/10/2024 | The Benchmark Company | Mark Miller | Strong Buy | Strong Buy |
5/10/2024 | Needham & Company | Charles Shi | Hold | Hold |
5/10/2024 | B. Riley Securities | Craig A Ellis | Strong Buy | Strong Buy |
4/16/2024 | Evercore Partners | Mark Lipacis | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.33 |
ABR (Last week) | 1.33 |
# of Recs in ABR | 6 |
Average Target Price | $259.00 |
LT Growth Rate | NA |
Industry | Nanotechnology |
Industry Rank by ABR | 5 of 252 |
Current Quarter EPS Est: | 1.19 |